| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| NKGen Biotech, Inc. | CSO and CIO | Common Stock | 28.4K | $93.4K | $3.29 | Sep 29, 2023 | Direct |
| NKGen Biotech, Inc. | CSO and CIO | Stock Option (right to buy) | 75K | Feb 12, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| NKGN | NKGen Biotech, Inc. | Feb 12, 2024 | 1 | $0 | 4 | Feb 14, 2024 | CSO and CIO |
| GFOR | NKGen Biotech, Inc. | Sep 29, 2023 | 0 | $0 | 3 | Oct 10, 2023 | CSO and CIO |